Regencell Bioscience Holdings (RGC) Peer Comparison
$5.50
As on 01-Sep-2026 16:00EDT
Market cap
$2,621 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2234.4
Div. Yield
0 %
| Regencell Bioscience Holdings (RGC) | MeiraGTx Holdings PLC (MGTX) | BeyondSpring - ADR | |
|---|---|---|---|
Market cap ($ Mln) |
2,621 | 1,327 | 27 |
Revenue ($ Mln) |
-- | 398 | -- |
Net Profit ($ Mln) |
-3.58 | 78.98 | -6.69 |
Net Margin (%) |
-- | 19.87 | -- |
RoE (%) |
-54.81 | -- | -- |
Price to Earnings |
-- | 16.26 | -- |
Price-To-Book |
2,234.44 | 6.30 | 5.38 |
Cashflow ($ Mln)
| Regencell Bioscience Holdings (RGC) | MeiraGTx Holdings PLC (MGTX) | BeyondSpring - ADR | |
|---|---|---|---|
|
Cash From Operating Activities
|
-3.11 | -46.36 | -20.02 |
|
Cash Flow from Investing Activities
|
2.69 | -4.11 | 13.48 |
|
Cash from Financing Activities
|
-- | 12.27 | 2.27 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- |
Ratios
Profitability Ratios
| Regencell Bioscience Holdings (RGC) | MeiraGTx Holdings PLC (MGTX) | BeyondSpring - ADR | |
|---|---|---|---|
|
ROCE (%)
|
-52.29 | -96.98 | 24.92 |
|
ROE (%)
|
-54.81 | -368.19 | 24.57 |
|
ROA (%)
|
-50.50 | -44.42 | -26.53 |
|
EBIT Margin (%)
|
-- | -- | -- |
|
Net Margin (%)
|
-- | -140.31 | -- |
|
Cash Profit Margin (%)
|
-- | -- | -- |
Growth Ratios
| Regencell Bioscience Holdings (RGC) | MeiraGTx Holdings PLC (MGTX) | BeyondSpring - ADR | |
|---|---|---|---|
|
Revenue Growth (%)
|
-- | 1.45 | -- |
|
EBIT Growth (%)
|
-- | -- | -- |
|
Net Profit Growth (%)
|
16.68 | 22.73 | 28.15 |
|
EPS Growth (%)
|
0.17 | 0.33 | 0.29 |
|
Book Value Growth (%)
|
-- | -- | -- |
Valuation Ratios
| Regencell Bioscience Holdings (RGC) | MeiraGTx Holdings PLC (MGTX) | BeyondSpring - ADR | |
|---|---|---|---|
|
Price / Earnings
|
-2,350.85 | -5.65 | -8.24 |
|
Price / Book Value
|
1,733.64 | -111.32 | -2.05 |
|
Dividend Yield (%)
|
-- | -- | -- |
|
EV/EBITDA
|
-2,638.78 | -7.47 | -6.28 |
|
Market Cap ($ Cr)
|
-- | -- | -- |
Solvency Ratios
| Regencell Bioscience Holdings (RGC) | MeiraGTx Holdings PLC (MGTX) | BeyondSpring - ADR | |
|---|---|---|---|
|
Debt to Equity
|
0.11 | -15.31 | -0.01 |
|
Short term debt to equity ratio
|
0.06 | -4.75 | -0.01 |
|
Current Ratio
|
7.39 | 0.75 | 1.54 |
|
Quick Ratio
|
-- | 0.75 | -- |
|
Interest Coverage
|
-- | -8.36 | -- |
Operating Efficiency Ratios
| Regencell Bioscience Holdings (RGC) | MeiraGTx Holdings PLC (MGTX) | BeyondSpring - ADR | |
|---|---|---|---|
|
Debtors to sales (%)
|
-- | 22.47 | -- |
|
Asset Turnover
|
-- | 0.32 | 0.00 |
|
Receivable days
|
-- | 64.88 | -- |
|
Inventory Days
|
-142.08 | 14.52 | -- |
|
Payable days
|
-- | 1,268.99 | 1,381.23 |
|
Cash Conversion Cycle
|
-- | -1,189.59 | -- |